62.51 USD
▼-3.28-4.99%
盘后 62.50 -0.02%
2026-09-15
市值
$5.89B
市盈率
—
EPS
-0.48
股息率
—
52 周区间
22.06 – 68.73
成交量
2.10M
Beta
1.06
目标价
74.21
52W 低 22.0652W 高 68.73
价格走势
公司简介
Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States. The company’s products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urin...